Application 209923
- Type
- ANDA
- Sponsor
- PRINSTON PHARMA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TOFACITINIB | TOFACITINIB | TABLET;ORAL | 5MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tofacitinib | TOFACITINIB | Novadoz Pharmaceuticals LLC | 253635c8-1ea7-41ba-b216-dea5e3305c47 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| TOFACITINIB | TOFACITINIB | Novadoz Pharmaceuticals LLC | 327f6b60-1a5d-49e6-acff-18603d0ee9d0 | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB TOFACITINIB |
| Tofacitinib | TOFACITINIB | Edenbridge Pharmaceuticals LLC. | 576722e5-6639-452d-a5c3-33a064f19481 | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| Tofacitinib | TOFACITINIB | Golden State Medical Supply, Inc. | 58f22c41-87d2-e745-e063-6394a90a962e | 2026-08-13 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| tofacitinib | TOFACITINIB | Zydus Pharmaceuticals USA Inc. | 179ffbb2-bedc-40e6-b77b-33d4f7832172 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | tofacitinib TOFACITINIB |
| Tofacitinib | TOFACITINIB | Macleods Pharmaceuticals Limited | 9b654f0d-7705-4880-9e9d-ad3a51e56b56 | 2026-08-06 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| Tofacitinib | TOFACITINIB | Apotex Corp. | 7d4f5cfa-35a8-1458-a609-f6b417946abb | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| Tofacitinib | TOFACITINIB | AvKARE | 5751321a-c904-44ae-e063-6394a90a2654 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| TOFACITINIB | TOFACITINIB | Aurobindo Pharma Limited | e54b186f-e42a-4477-939c-8dd331045fbe | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB TOFACITINIB |
| TOFACITINIB | TOFACITINIB | Aurobindo Pharma Limited | 50962b08-99dd-ae73-e063-6394a90ad1eb | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB TOFACITINIB |
| TOFACITINIB | TOFACITINIB | IPG Pharmaceuticals, Inc | cd1b61bf-de03-4198-89f6-f3952b79d2c2 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB TOFACITINIB |
| tofacitinib solution | TOFACITINIB | Hikma Pharmaceuticals USA Inc. | d9cf18a9-e825-49ac-b080-68957c0e79ae | 2026-07-01 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB |
| TOFACITINIB | TOFACITINIB | Orient Pharma Co., Ltd. Yunlin Plant | 5617a652-a78e-74b1-e063-6394a90a31c7 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB TOFACITINIB |
| Tofacitinib | TOFACITINIB | AvKARE | 5502f252-2b39-2cfd-e063-6394a90a8a48 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| Tofacitinib | TOFACITINIB | Ajanta Pharma USA Inc. | 024bb9f2-8c26-4d9d-a33b-eb3c0a7c59ed | 2026-06-05 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| TOFACITINIB | TOFACITINIB | Somerset Therapeutics, LLC | 2726c2b0-c763-4635-ac6b-4334c3a5a8bc | 2026-06-02 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB TOFACITINIB |
| tofacitinib | TOFACITINIB | Zydus Lifesciences Limited | f4d0e580-74a8-496e-89a2-d74478c946bf | 2026-05-29 | tofacitinib TOFACITINIB | |
| Tofacitinib | TOFACITINIB CITRATE | Breckenridge Pharmaceutical, Inc. | c963c610-52e5-43ab-aac6-3f7e5341b764 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | Tofacitinib |
| tofacitinib | TOFACITINIB | Zydus Lifesciences Limited | ac0b26d5-1352-42ff-b5ea-3eb02d8508a4 | 2026-05-12 | tofacitinib TOFACITINIB | |
| TOFACITINIB | TOFACITINIB | Exelan pharmaceuticals,Inc | e68680e5-0328-4e66-b8bb-4af126221ec7 | 2026-05-01 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB TOFACITINIB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 55953 | ORIG | 2018-10-17 |